After a successful 17-year partnership, BNP Paribas is looking to acquire up to 100% of Exane*, raising its stake from the 50% currently held.
Read more: https://group.bnpparibas/en/press-release/bnp-paribas-acquire-100-exaneBNP Paribas Hong Kong Branch Financial Disclosure Statement
- 2022 Quarterly Financial Disclosure (as at 31 March 2022)
- 2022 BNP Paribas Securities Services Hong Kong Branch Quarterly Financial Disclosure (as at 31 March 2022)
- 2021 Annual Financial Disclosure
- 2021 BNP Paribas Securities Services Hong Kong Branch Annual Financial Disclosure (as at 31 December 2021)
- 2021 BNP Paribas Securities Services Hong Kong Branch Quarterly Financial Disclosure (as at 30 September 2021)
- 2021 Quarterly Financial Disclosure (as at 30 September 2021)
- 2021 Interim Financial Disclosure
- 2021 Quarterly Financial Disclosure (as at 31 March 2021)
- 2020 Annual Financial Disclosure
- 2020 Quarterly Financial Disclosure (as at 30 September 2020)
- 2020 Interim Financial Disclosure
- 2020 Quarterly Financial Disclosure (as at 31 March 2020)
- 2019 Annual Financial Disclosure
- 2019 Quarterly Financial Disclosure (as at 30 September 2019)
- 2019 Interim Financial Disclosure
- 2019 Quarterly Financial Disclosure (as at 31 March 2019)
- 2018 Annual Financial Disclosure
- 2018 Quarterly Financial Disclosure (as at 30 September 2018)
- 2018 Interim Financial Disclosure
- 2017 Annual Financial Disclosure
- 2017 Interim Financial Disclosure
- 2016 Annual Financial Disclosure
- 2016 Interim Financial Disclosure
- 2015 Annual Financial Disclosure
- 2015 Interim Financial Disclosure